Modern Chinese Medicine Group Co Ltd Ordinary Shares 01643
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$0.39
- Day Range
- HK$0.35–0.38
- 52-Week Range
- HK$0.30–3.26
- Bid/Ask
- HK$0.35 / HK$0.36
- Shares Outstanding
- 720.00M
- Market Cap
- HK$255.60M
- Volume/Avg
- 222,600 / 322,456
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.15
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills, among others. Geographically, the company derives its key revenue from the People's Republic of China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Value
- Total Number of Employees
- 189
- Website
- http://www.cdysjdyy.com
Valuation
Metric | 01643 |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.47 |
Price/Sales | 1.15 |
Price/Cash Flow | — |
Price/Earnings
01643
Financial Strength
Metric | 01643 |
|---|---|
Quick Ratio | 7.26 |
Current Ratio | 9.12 |
Interest Coverage | −857.70 |
Quick Ratio
01643
Profitability
Metric | 01643 |
|---|---|
Return on Assets (Normalized) | −7.98% |
Return on Equity (Normalized) | −8.66% |
Return on Invested Capital (Normalized) | −8.64% |
Return on Assets
01643
Drug Manufacturers - General Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Eli Lilly and Co LLY | LOCK|$V@q^^& | LOCK|x<d | $1T | |||
| Johnson & Johnson JNJ | LOCK|z!fp$l | LOCK|dF | $665B | |||
| AbbVie Inc ABBV | LOCK|w>#^t! | LOCK|Pl | $515B | |||
| Roche Holding AG ADR RHHBY | LOCK|#Q&nVlS | LOCK|b? | $383B | |||
| Merck & Co Inc MRK | LOCK|t^j&z^ | LOCK|SL# | $362B | |||
| Novartis AG ADR NVS | LOCK|&!Pw^fL | LOCK|M#y | $308B | |||
| AstraZeneca PLC AZN | LOCK|&%qz!&< | LOCK|Y& | $291B | |||
| Amgen Inc AMGN | LOCK|XZ>KntsJ | LOCK|pY | $249B | |||
| Gilead Sciences Inc GILD | LOCK|%!ndy$ | LOCK|@M | $207B | |||
| Novo Nordisk AS ADR NVO | LOCK|Yl%frs | LOCK|?sP | $178B |
United States